Dime La VerDAD: Verify, Debunk, and Disseminate

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-99
SponsorUniversity of Chicago

About this trial

Dime la Verdad (Tell me the truth) will evaluate the use of storytelling by community health workers as a communication strategy to disseminate reliable health information on social media and encourage informed decision-making in favor of recommended immunizations in communities with high morbidity and mortality due to respiratory virus infections.

Dime La Verdad is an innovative social media capacity-building program based on theoretical frameworks related to health communication that empowers community health workers to disseminate reliable information about respiratory virus protection strategies through the use of personal narratives on social media. The proposed work will use a rigorous stepped wedge design to 1) deliver a scalable program of science communicators using an adapted curriculum grounded in principles of health communication, 2) evaluate how diffusion of health messaging is perceived on social media, and 3) discern how use of personal narratives to enhance science communication can encourage informed decision-making to promote evidence-based immunization practices and improve health outcomes.

Eligibility criteria

Qualifiers

18 years or older

Fluent in English or Spanish

Provide services as a community health worker or similar designation in at least one of the seven communities with high morbidity and mortality due to respiratory virus infections

Have a social media presence (personal or work related)

Disqualifiers

Plan to stop working as a community health worker or similar designation before spring of 2028 (end of data collection planned)

Do not wish to participate in a social media campaign

Trial design

Treatments tested in this trial

  • Science Communication Curriculum Cohort 1
  • Science communication curriculum Cohort 2
  • Science communication curriculum Cohort 3
  • Science communication curriculum Cohort 4

Treatment groups

1,400 Participants
are divided into 5 treatment groups

Sponsors and collaborators

University of Chicago

Lead sponsor

University of Iowa

Collaborator

University of Michigan

Collaborator

Rush University Medical Center

Collaborator

Bedford Research Corporation, Inc.

Collaborator

Tanoma Consulting

Collaborator

National Institute on Minority Health and Health Disparities (NIMHD)

Collaborator